Novel strategy for oral peptide delivery in incretin-based diabetes treatment

OBJECTIVE: To fulfil an unmet therapeutic need for treating type 2 diabetes by developing an innovative oral drug delivery nanosystem increasing the production of glucagon-like peptide-1 (GLP-1) and the absorption of peptides into the circulation. DESIGN: We developed a nanocarrier for the oral deli...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yining, Van Hul, Matthias, Suriano, Francesco, Préat, Véronique, Cani, Patrice D, Beloqui, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229891/
https://www.ncbi.nlm.nih.gov/pubmed/31401561
http://dx.doi.org/10.1136/gutjnl-2019-319146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229891/
https://www.ncbi.nlm.nih.gov/pubmed/31401561
http://dx.doi.org/10.1136/gutjnl-2019-319146

Ejemplares similares